Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAT1: Suramin in autism spectrum disorders
NCT02508259Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- May 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of suramin in Autism Spectrum Disorder (ASD), sponsored by University of California, San Diego. Started May 2015; status: completed.
02
Drugs
suramin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT02508259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02508259.